Truentity Corporation

Based in the US, Truentity Corporation provides innovative AI solutions for pharmacy-led clinical care, enhancing patient outcomes and streamlining medication management processes. Truentity Corporation, founded in 2020, is located in Chapel Hill, US. The company specializes in AI-driven solutions for pharmacies to improve clinical care. It has secured Series A funding of USD 3.

5 mn led by Evidenced, with additional investments from K Street Capital Fund Management Company, Cofounders Capital, Metrodora Ventures, and Triangle Tweener Fund. The funding, raised in April 2026, will be used to scale its pharmacy-led clinical care delivery network nationwide. The firm has completed a total of 1 deal to date. Truentity Health's primary offering is Aora, an AI operating system designed to enhance pharmacy-led clinical care.

Aora automates clinical workflows, identifies patient risks, and transforms data into actionable insights for pharmacists, thereby addressing critical needs in medication management and patient care. The platform enables pharmacies to implement reimbursable clinical services with ease, streamlining operations across technology, medical billing, compliance, and physician oversight. The end users of Truentity's solutions include community pharmacies, healthcare providers, and payers, all of which benefit from improved patient outcomes and new revenue streams. Truentity’s services are available primarily in the United States, focusing on expanding access to value-based care through its innovative pharmacy collaborations.

Truentity Health generates revenue through partnerships with pharmacies, healthcare providers, and payers, facilitating the integration of AI into pharmacy operations. The company's revenue structure primarily includes subscriptions for its Aora platform, which allows pharmacies to access its suite of clinical tools and solutions. By leveraging Aora, pharmacies can implement workflows that lead to measurable patient outcomes and unlock new clinical revenue streams. The firm’s focus on creating a sustainable revenue model is evident in its emphasis on reimbursable clinical services, aligning its offerings with payer requirements and value-based care programs.

Specific pricing plans for the services are tailored to the needs of client pharmacies, enhancing the overall financial viability of their operations. In April 2026, Truentity Corporation raised USD 3. 5 mn in Series A funding led by Evidenced, with support from K Street Capital Fund Management Company, Cofounders Capital, Metrodora Ventures, and Triangle Tweener Fund. The company plans to use the funding to scale its pharmacy-led clinical care delivery network nationwide and expand access to chronic disease management through community pharmacies.

Upcoming initiatives involve launching new features for the Aora platform designed to address emerging health care needs, with specific release dates to be announced. Truentity aims to enhance its market presence, particularly in underserved regions, as part of its broader strategy for growth.